Ghadeer Dawwas, PhD, MSc, MBA is a postdoctoral fellow in the Department of Epidemiology, Biostatistics and informatics at the Perelman School of Medicine of the University of Pennsylvania. Dr. Dawwas’s research focuses on the comparative effectiveness and safety of medical products in selected patients’ populations who were often excluded or underrepresented in randomized clinical trials. She received the best second abstract award from the International Society of Pharmacoepidemiology (ISPE) for her work examining the risk of cardiovascular diseases with sodium-glucose co-transporter inhibitors in patients with type 2 diabetes, one of the most read articles between 2018-2019 in Diabetes, Obesity and Metabolism. Her work on the safety of apixaban, which was published in the Lancet Hematology, received the best poster award from the International Society of Pharmacoeconomics and Health Outcomes Research (ISPOR). In addition to these areas, Dr. Dawwas has investigated antiplatelet therapy in patients with acute coronary syndrome, risk of heart failure in users of dipeptidyl peptidase-4 inhibitors, and utilization of medications. In 2017, Dr. Dawwas received an American Association of University Women (AAUW) Fellowship. Dr. Dawwas earned her degree in Pharmacy from the University of Jordan and an MBA from Stratford University in Richmond, Virginia. She earned a Masters and PhD in Pharmacoepidemiology from the University of Florida.
Ghadeer Dawwas, PhD, MSc, MBA
- Postdoctoral Fellow, Epidemiology and Biostatistics, Perelman School of Medicine
In The Media TCTMD
In The Media Healthline
In The Media Medpage Today